Posted on 5/13/19
Arch Therapeutics $2.8M Registered Direct Offering
FRAMINGHAM, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH), a developer of novel liquid, gel and solid hemostatic and wound care devices, . . .
Posted on 5/13/19
Adlon Therapeutics to Provide Funding Opportunities for Research to Expand Understanding of ADHD
STAMFORD, Conn.--(BUSINESS WIRE)--Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., today announced it will issue a funding opportunity for investigator-initiated research (IIR) studies to contribute . . .
Posted on 5/13/19
Arch Therapeutics $2.8 Million Registered Direct Offering
FRAMINGHAM, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH), a developer of novel liquid, gel and solid hemostatic and wound care devices, . . .
Posted on 5/13/19
ElevateBio Launches to Create and Operate a Portfolio of Highly Innovative Cell and Gene Therapy Companies
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ElevateBio, a Cambridge-based biotechnology holding company, today announced operations to create and build a broad portfolio of cell and gene therapy companies through partnerships . . .
Posted on 5/13/19
Myomo Reports First Quarter 2019 Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, . . .
Posted on 5/13/19
AVROBIO Reports First Quarter 2019 Financial Results and Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (NASDAQ: AVRO), a Phase 2 clinical-stage gene therapy company, today reported financial results for the first quarter ended March 31, 2019 and . . .
Posted on 5/13/19
Vedanta Biosciences Closes Extended $45.5 Million Series C Financing
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria
Posted on 5/13/19
Unum Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update
CAMBRIDGE, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat . . .
Posted on 5/13/19
Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company
CAMBRIDGE, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company focused on the development of soluble guanylate cyclase (sGC) . . .
Posted on 5/9/19
J.D. Power Names Blue Cross Blue Shield of Massachusetts Top Plan In State For Third Year In A Row
Blue Cross Blue Shield of Massachusetts was named the top health plan in Massachusetts for member satisfaction for the third year in a row by J.D. . . .
Posted on 5/9/19
NMC Health PLC Acquires Boston IVF
NMC Health plc, the London Stock Exchange listed healthcare company with international services across 19 countries has acquired a majority stake in Boston IVF
Posted on 5/9/19
Compass Diversified Holdings Sells Clean Earth for $625M
Compass Diversified Holdings (NYSE: CODI), an owner of leading middle market businesses, announced today that Compass Group Diversified Holdings LLC
Posted on 5/9/19
Mersana Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Updates
CAMBRIDGE, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug . . .
Posted on 5/9/19
Boston Scientific To Acquire Vertiflex For $465M
Boston Scientific (NYSE:BSX) has agreed to acquire privately-held Vertiflex, the developer of a device to improve physical function and reduce pain in lumbar spinal stenosis patients
Posted on 5/9/19
Axcella Health Prices IPO
CAMBRIDGE, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Axcella Health Inc., a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated . . .
Posted on 5/8/19
Gilead Sciences And Goldfinch Bio Announce Strategic Collaboration
-- Companies to Pursue a Human Genetics Approach to Drug Discovery and Development --Gilead Sciences, Inc. (Nasdaq: GILD) and Goldfinch Bio, Inc., a biotechnology company focused . . .
Posted on 5/8/19
CVS Health Ranks #27 on DiversityInc's 2019 Top 50 Companies for Diversity List
CVS Health has earned a spot on DiversityInc's Top 50 Companies for Diversity list for the third consecutive year. This year's #27 ranking, up 13 spots . . .
Posted on 5/8/19
IFM Therapeutics and Novartis Complete Previously Announced Acquisition of IFM Tre
IFM Therapeutics (IFM), a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, announced today the completion of the . . .
Posted on 5/8/19
Bristol-Myers Squibb Company Prices $19 Billion of Senior Unsecured Notes
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced that it priced its previously announced private offering of senior unsecured notes in a combined aggregate principal amount . . .
Posted on 5/8/19
Arvinas Reports First Quarter Financial Results and Provides Corporate Update
NEW HAVEN, Conn., May 08, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company creating a new class of therapies that degrades disease-causing proteins, . . .
Posted on 5/8/19
Jounce Therapeutics Reports First Quarter 2019 Financial Results
CAMBRIDGE, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 5/8/19
Gilead Sciences And Goldfinch Bio Announce Strategic Collaboration
Gilead Sciences, Inc. (Nasdaq: GILD) and Goldfinch Bio, Inc., a biotechnology company focused on developing precision therapies for patients with kidney diseases, today announced a strategic . . .
Posted on 5/8/19
Trevi Therapeutics Prices IPO
NEW HAVEN, Conn., May 07, 2019 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to . . .
Posted on 5/8/19
Infinity Pharmaceuticals Provides Company Update
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its first quarter 2019 financial results and provided an update on the company, including its progress in expanding the . . .
Posted on 5/8/19
Horizon Technology Finance Provides $5 Million Venture Loan Facility to Meditrina
Horizon Technology Finance Corporation (NASDAQ: HRZN), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in . . .

